Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
Pritha Ghosh, View ORCID ProfileMichiel J.M. Niesen, Colin Pawlowski, Hari Bandi, Unice Yoo, View ORCID ProfilePatrick J. Lenehan, Praveen Kumar M., Mihika Nadig, Jason Ross, Sankar Ardhanari, John C. O’Horo, AJ Venkatakrishnan, Clifford J. Rosen, Amalio Telenti, Ryan T. Hurt, View ORCID ProfileVenky Soundararajan
doi: https://doi.org/10.1101/2022.11.30.22282831
Pritha Ghosh
1nference Labs, Bengaluru, India
Michiel J.M. Niesen
2nference, inc., Cambridge, Massachusetts 02139, USA
Colin Pawlowski
2nference, inc., Cambridge, Massachusetts 02139, USA
Hari Bandi
2nference, inc., Cambridge, Massachusetts 02139, USA
Unice Yoo
2nference, inc., Cambridge, Massachusetts 02139, USA
Patrick J. Lenehan
2nference, inc., Cambridge, Massachusetts 02139, USA
Praveen Kumar M.
1nference Labs, Bengaluru, India
Mihika Nadig
2nference, inc., Cambridge, Massachusetts 02139, USA
Jason Ross
3nference, inc., 18 3rd St. S.W., Rochester MN 55902, USA
Sankar Ardhanari
4nference, inc. 2424 Erwin Road, Durham, NC 27705, USA
John C. O’Horo
5Mayo Clinic, Rochester, MN, USA
AJ Venkatakrishnan
2nference, inc., Cambridge, Massachusetts 02139, USA
Clifford J. Rosen
6Maine Medical Center, Portland, ME 04102, USA
7NIH RECOVER Initiative, USA
Amalio Telenti
8Vir Biotechnology, inc., San Francisco, CA, USA
Ryan T. Hurt
5Mayo Clinic, Rochester, MN, USA
Venky Soundararajan
1nference Labs, Bengaluru, India
2nference, inc., Cambridge, Massachusetts 02139, USA
3nference, inc., 18 3rd St. S.W., Rochester MN 55902, USA
4nference, inc. 2424 Erwin Road, Durham, NC 27705, USA
9Anumana, inc., Cambridge, Massachusetts 02139, USA
Data Availability
After publication, the data will be made available to others upon reasonable requests to the corresponding author. A proposal with a detailed description of the study objectives and the statistical analysis plan will be needed for evaluation of the reasonability of requests.
Posted December 01, 2022.
Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
Pritha Ghosh, Michiel J.M. Niesen, Colin Pawlowski, Hari Bandi, Unice Yoo, Patrick J. Lenehan, Praveen Kumar M., Mihika Nadig, Jason Ross, Sankar Ardhanari, John C. O’Horo, AJ Venkatakrishnan, Clifford J. Rosen, Amalio Telenti, Ryan T. Hurt, Venky Soundararajan
medRxiv 2022.11.30.22282831; doi: https://doi.org/10.1101/2022.11.30.22282831
Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
Pritha Ghosh, Michiel J.M. Niesen, Colin Pawlowski, Hari Bandi, Unice Yoo, Patrick J. Lenehan, Praveen Kumar M., Mihika Nadig, Jason Ross, Sankar Ardhanari, John C. O’Horo, AJ Venkatakrishnan, Clifford J. Rosen, Amalio Telenti, Ryan T. Hurt, Venky Soundararajan
medRxiv 2022.11.30.22282831; doi: https://doi.org/10.1101/2022.11.30.22282831
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2780)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12430)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4297)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4072)
- Nursing (218)
- Nutrition (603)
- Oncology (2154)
- Ophthalmology (608)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6677)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)